JB Chemicals gets USFDA nod to market generic medication

JB Chemicals gets USFDA nod to market generic medication The company has received approval from the US Food and Drug Administration to market Doxepin Hydrochloride capsules in strengths of 10 mg, 25 mg, 50 mg, 75 mg, and 100 mg, JB Chemicals Pharmaceuticals said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/DSU3aLO
Posted by: at
Tags:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...